Is There Any Relation Between Pseudoexfoliation Syndrome and Alzheimer’s Type Dementia?

References

• Naumann GO, Schlotzer-Schrehardt U, Kuchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: Intraocular and systemic manifestations. Ophthalmology 1998;105:951–968
   PubMed Web of Science ®Google Scholar
• Rocchi A, Pellegrini S, Siciliano G and Murri L. Causative and susceptibility genes for Alzheimer’s disease: A review. Brain Res Bull 2003;61:1–24
   PubMed Web of Science ®Google Scholar
• Damji KF, Bains HS, Stefansson E, et al. In psedoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet 1998;19:175–185
   PubMedGoogle Scholar
• Lowe J, Landon M, Pike I, et al. Dementia with beta-amyloid deposition: Involvement of alpha B-crystallin supports two main diseases. Lancet 1990;336:515–516
   PubMedGoogle Scholar
• Selkoe DJ. Alzheimer’s disease: Genes, proteins, and therapy. Physiol Rev 2001;8:741–766
   Google Scholar
• Loffler KU, Edward DP, Tso MO. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci 1995;36:24–31
   PubMed Web of Science ®Google Scholar
• Janciauskiene S, Wright HT. Inflammation, antichymotrypsin, and lipid metabolism: Autogenic etiology of Alzheimer’s disease. Bioessays 1998;20:1039–1046
   PubMed Web of Science ®Google Scholar
• Boskovic G, Twining SS. Local control of alpha-1-proteinase inhibitor levels: Regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines. Biochem Biophys Acta 1998;1403:37–46
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Ozyurt H, Deniz Demir H, Yardim H. Serum alpha-1-antityripsin evels in patients with pseudoexfolation syndrome. Curr Eye Res 2008;33(2):159–162
   Web of Science ®Google Scholar
• Linner E, Popovic V, Gottfries CG, et al. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer’s type. Acta Ophthalmol Scand 2001;79:283–285
   PubMedGoogle Scholar
• Reniewska B, Mulak M, Misiuk-Hojło M, Kostuś E. Coexistence of Alzheimer's disease with pseudoexfoliation syndrome PEX. Klin Oczna 2004;106:107–109
   PubMedGoogle Scholar
• Hodapp E, Parrish RK II, Anderson DR. Clinical decisions in glaucoma. St. Louis: The CV Mosby Co., 1993; 52–61
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 2000
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1973;12:189–198
   Web of Science ®Google Scholar
• Güngen C, Ertan T, Eker E, et al. Reliability and validity of the Standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population. Turkish Journal of Psychiatry 2002;13:273–281
   Google Scholar
• Ertan T, Eker E, Gungen C, et al. The Standardized Mini Mental State Examination for illiterate Turkish elderly population. Second International Symposium on Neurophysiological and Neuropsychological Assessment of Mental and Behavioral Disorders, 28–30 Aug 1999, Bursa, Turkey
   Google Scholar
• Janciauskiene S, Krakau T. Alzheimer’s peptide: A possible link between glaucoma, exfoliation syndrome and Alzheimer’s disease. Acta Ophthalmol Scand 2001;79:328–329
   PubMedGoogle Scholar
• Janciauskiene S, Westin K, Krakau T. Detection of Alzheimer’s peptides and chemokines in the aqueous humor. Eur J Ophthalmol 2011;21:104–111
   PubMed Web of Science ®Google Scholar
• Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002;47(3):165–168
   PubMed Web of Science ®Google Scholar
• Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006;246:79–83
   PubMed Web of Science ®Google Scholar
• Wostyn P, Audenaert K, De Deyn PP. Alzheimer’s disease and glaucoma: Is there a casual relation? Br J Ophthalmol 2009;93:1557–1559
   PubMed Web of Science ®Google Scholar
• Zhuo JM, Wang H, Praticò D. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 2011;32(9):562–571
   PubMed Web of Science ®Google Scholar
• Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol 2004;138:162–164
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 2006;23(6):6
   Google Scholar
• Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346(7):476–483
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Tamer L, Ates NA, et al. Effects of apolipoprotein E genotypes on the development of exfoliation syndrome. Exp Eye Res 2005;80:871–875
   PubMed Web of Science ®Google Scholar
• Panayotou G, End P, Aumailley M, et al. Domains of laminin with growth-factor activity. Cell 1989;56:93–101
   PubMed Web of Science ®Google Scholar
• Villa A, Latasa MJ, Pascual A. Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells. J Neurochem 2001;77:1077–1084
   Google Scholar
• Faller P. Copper and zinc binding to amyloid-beta: Coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chembiochem 2009;10(18):2837–2845
   Google Scholar
• Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000;39(23):7024–7031
   Google Scholar
• Cumurcu T, Mendil D, Etikan I. Levels of zinc, iron, and copper in patients with pseudoexfoliative cataract. Eur J Ophthalmol 2006;16(4):548–553
   PubMed Web of Science ®Google Scholar
• Hölscher C. Diabetes as a risk factor for Alzheimer's disease: Insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Biochem Soc Trans 2011;39(4):891–897
   PubMedGoogle Scholar
• Ciobica A, Padurariu M, Bild W, Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. Psychiatr Danub 2011;23(4):340–346
   Google Scholar
• Hammer T, Schlötzer-Schrehardt U, Jünemann A. Unilateral or asymmetric PEX syndrome? An electron microscopy study. Klin Monbl Augenheilkd 2000;217(2): 100–108
   Google Scholar
• Ganguli M, Dodge HH, Chen P, et al. Ten-year incidence of dementia in a rural elderly US community population: The MoVIES Project. Neurology. 2000;54(5):1109–1116
   Google Scholar
• Kawas C, Gray S, Brookmeyer R, et al. Age-specific incidence rates of Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology. 2000;54(11):2072–2077
   PubMed Web of Science ®Google Scholar